PhaseBio Pharmaceuticals, Inc.'s ticker is and the CUSIP is 717224100. A total of 1 filers reported holding PhaseBio Pharmaceuticals, Inc. in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -71.4% | 34,208 | 0.0% | 0.00% | -75.0% |
| Q2 2022 | $21,000 | -53.3% | 34,208 | 0.0% | 0.01% | -20.0% |
| Q1 2022 | $45,000 | -49.4% | 34,208 | 0.0% | 0.01% | -9.1% |
| Q4 2021 | $89,000 | -16.0% | 34,208 | 0.0% | 0.01% | -38.9% |
| Q3 2021 | $106,000 | -16.5% | 34,208 | 0.0% | 0.02% | -55.0% |
| Q2 2021 | $127,000 | +7.6% | 34,208 | 0.0% | 0.04% | +5.3% |
| Q1 2021 | $118,000 | +2.6% | 34,208 | 0.0% | 0.04% | -11.6% |
| Q4 2020 | $115,000 | -4.2% | 34,208 | 0.0% | 0.04% | -25.9% |
| Q3 2020 | $120,000 | -23.6% | 34,208 | 0.0% | 0.06% | -31.0% |
| Q2 2020 | $157,000 | +38.9% | 34,208 | 0.0% | 0.08% | +29.2% |
| Q1 2020 | $113,000 | -45.9% | 34,208 | 0.0% | 0.06% | -29.3% |
| Q4 2019 | $209,000 | +46.2% | 34,208 | 0.0% | 0.09% | +53.3% |
| Q3 2019 | $143,000 | -68.2% | 34,208 | 0.0% | 0.06% | -73.1% |
| Q2 2019 | $449,000 | – | 34,208 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HAMILTON LANE ADVISORS LLC | 34,208 | $127,000 | 0.04% |